German medical device manufacturer BellaSeno has announced that its proprietary 3D printed breast implants have entered human trials. BellaSeno’s 3D printed breast scaffolds are fully-resorbable…
Regemat 3 d /€500k in effort to advance its 3D bioprinting technology
Spanish 3D bioprinting specialist Regemat 3D has raised more than €500,000 in equity crowdfunding. Announced late last year, the funding round has seen Regemat 3D gain the backing of over 500 in…
CollPlant to trial 3D bioprinted breast implants in breakthrough animal study
Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future. Alongside the…
CollPlant partners with CELLINK in bid to address $2.8BN regenerative breast implant market
Regenerative medicine specialist CollPlant has partnered with BICO firm CELLINK in an effort to ramp up its production of 3D bioprinted breast implants. Currently undergoing preclinical trials, …
Nuclera raises $42.5M towards launch of new protein 3D printer that “makes drug discovery accessible”
Insiders and analysts have made their predictions on the 3D printing trends to watch out for. Find out more in our series focused on the future of 3D printing. Biotechnology start-up Nuclera has …
Matricelf licenses patent for 3D bioprinting tissues and organs from TAU
Israeli regenerative medicine firm Matricelf has signed an exclusive global licensing agreement with Tel Aviv University (TAU) technology transfer firm Ramot for a patent-pending 3D bioprinting techno…
Healshape to raise $6.8M to advance its breast implant 3D bioprinting technology
Insiders and analysts predict the 3D printing trends to watch in our latest series of articles focused on the future of 3D printing. Healshape, a Lyon, France-based regenerative medicine startup, is e…